Shenwei Pharmaceutical (02877.HK) released its interim results with a net profit of 615 million yuan during the period, a year-on-year decrease of 1.89%.

Zhtng Cijng APP news, Shenwei Pharmaceutical (02877.HK) released its mid-year performance for 2025, with a revenue of 1.653 billion yuan, a decrease of 20.8% year-on-year; a net profit of 615 million yuan, a decrease of 1.89% year-on-year; basic earnings per share of 0.81 yuan; and a proposed interim dividend of 0.11 yuan per share.